In order to verify that the rights, safety and well-being of subjects are protected, that the reported data are reliable and robust, and that the conduct of the clinical trial is in compliance with the requirements of this Regulation, the sponsor shall adequately monitor the conduct of a clinical trial. The extent and nature of the monitoring shall be determined by the sponsor on the basis of an assessment that takes into consideration all characteristics of the clinical trial, including the following characteristics:

1. (a)

   whether the clinical trial is a low-intervention clinical trial;

2. (b)

   the objective and methodology of the clinical trial; and

3. (c)

   the degree of deviation of the intervention from normal clinical practice.